These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35412139)

  • 1. Broad-spectrum Respiratory Virus Entry Inhibitors.
    Zhao H; Yuen KY
    Adv Exp Med Biol; 2022; 1366():137-153. PubMed ID: 35412139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum antivirals against viral fusion.
    Vigant F; Santos NC; Lee B
    Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
    Lu S; Pan X; Chen D; Xie X; Wu Y; Shang W; Jiang X; Sun Y; Fan S; He J
    Bioorg Chem; 2021 Feb; 107():104619. PubMed ID: 33450541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses.
    Zheng Y; Li S; Song K; Ye J; Li W; Zhong Y; Feng Z; Liang S; Cai Z; Xu K
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.
    Groß R; Dias Loiola LM; Issmail L; Uhlig N; Eberlein V; Conzelmann C; Olari LR; Rauch L; Lawrenz J; Weil T; Müller JA; Cardoso MB; Gilg A; Larsson O; Höglund U; Pålsson SA; Tvilum AS; Løvschall KB; Kristensen MM; Spetz AL; Hontonnou F; Galloux M; Grunwald T; Zelikin AN; Münch J
    Adv Sci (Weinh); 2022 Jul; 9(20):e2201378. PubMed ID: 35543527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
    Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
    Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.
    Zelikin AN; Stellacci F
    Adv Healthc Mater; 2021 Mar; 10(6):e2001433. PubMed ID: 33491915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals with common targets against highly pathogenic viruses.
    Lu L; Su S; Yang H; Jiang S
    Cell; 2021 Mar; 184(6):1604-1620. PubMed ID: 33740455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting viral entry as a strategy for broad-spectrum antivirals.
    Mazzon M; Marsh M
    F1000Res; 2019; 8():. PubMed ID: 31559009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses.
    Maarifi G; Martin MF; Zebboudj A; Boulay A; Nouaux P; Fernandez J; Lagisquet J; Garcin D; Gaudin R; Arhel NJ; Nisole S
    Cell Chem Biol; 2022 Jul; 29(7):1113-1125.e6. PubMed ID: 35728599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.
    Narayan R; Sharma M; Yadav R; Biji A; Khatun O; Kaur S; Kanojia A; Joy CM; Rajmani R; Sharma PR; Jeyasankar S; Rani P; Shandil RK; Narayanan S; Rao DC; Satchidanandam V; Das S; Agarwal R; Tripathi S
    Cell Rep Med; 2023 Aug; 4(8):101127. PubMed ID: 37463584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention strategies for emerging viruses: use of antivirals.
    Debing Y; Jochmans D; Neyts J
    Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A broad-spectrum antiviral targeting entry of enveloped viruses.
    Wolf MC; Freiberg AN; Zhang T; Akyol-Ataman Z; Grock A; Hong PW; Li J; Watson NF; Fang AQ; Aguilar HC; Porotto M; Honko AN; Damoiseaux R; Miller JP; Woodson SE; Chantasirivisal S; Fontanes V; Negrete OA; Krogstad P; Dasgupta A; Moscona A; Hensley LE; Whelan SP; Faull KF; Holbrook MR; Jung ME; Lee B
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3157-62. PubMed ID: 20133606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
    Brooks MJ; Sasadeusz JJ; Tannock GA
    Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses.
    He Y; Zhou J; Gao H; Liu C; Zhan P; Liu X
    Eur J Med Chem; 2024 Feb; 265():116069. PubMed ID: 38160620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
    Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.